Literature DB >> 9820600

Expression of HLA class I antigens in transporter associated with antigen processing (TAP)-deficient mutant cell lines.

N T Young1, A Mulder, V Cerundolo, F H Claas, K I Welsh.   

Abstract

Cells lacking expression of the transporter associated with antigen processing (TAP) are deficient in surface HLA class I, yet express reduced levels of HLA-A2 antigen through TAP-independent processing pathways. We have analysed the expression of HLA-A, -B and -C antigens on the 721.174 and T2 TAP-deficient mutant cell lines using a panel of monoclonal antibodies specific for the HLA antigens encoded by the genotype of these cells. Our study has shown the constitutive expression of HLA-Cw1 molecules on the cell surface of both T2 and 721.174 cells and has confirmed that HLA-A2 and HLA-B51 are expressed at low levels. Transfection of 721.174 cells with cDNAs encoding TAP1 and TAP2 proteins did not fully restore HLA class I antigen expression on these cells, which appeared to be mainly due to a deficiency in expression of the HLA-B51-associated Bw4 epitope. This suggests that additional antigen-processing genes may be required for optimal generation of HLA-B-binding peptides. Our results indicate that TAP-independent pathways of antigen-processing provide peptides for functional expression of all three classical HLA class I molecules.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9820600     DOI: 10.1111/j.1399-0039.1998.tb03057.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  11 in total

1.  Peptide antagonism as a mechanism for NK cell activation.

Authors:  Lena Fadda; Gwenoline Borhis; Parvin Ahmed; Kuldeep Cheent; Sophie V Pageon; Angelica Cazaly; Stavros Stathopoulos; Derek Middleton; Arend Mulder; Frans H J Claas; Tim Elliott; Daniel M Davis; Marco A Purbhoo; Salim I Khakoo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

2.  Cytosolic Processing Governs TAP-Independent Presentation of a Critical Melanoma Antigen.

Authors:  Nathalie Vigneron; Violette Ferrari; Benoît J Van den Eynde; Peter Cresswell; Ralf M Leonhardt
Journal:  J Immunol       Date:  2018-08-22       Impact factor: 5.422

3.  Altered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis: correlation of TAP-1 with disease.

Authors:  A Vambutas; V R Bonagura; B M Steinberg
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

4.  Major histocompatibility complex class I-restricted alloreactive CD4+ T cells.

Authors:  Louise H Boyle; Jane C Goodall; J S Hill Gaston
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

5.  HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function.

Authors:  Lena Fadda; Christian Körner; Swati Kumar; Nienke H van Teijlingen; Alicja Piechocka-Trocha; Mary Carrington; Marcus Altfeld
Journal:  PLoS Pathog       Date:  2012-07-12       Impact factor: 6.823

6.  Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one.

Authors:  Daniela Fenoglio; Alessia Parodi; Rosa Lavieri; Francesca Kalli; Francesca Ferrera; Augusto Tagliamacco; Andrea Guastalla; Maria Giuseppina Lamperti; Mauro Giacomini; Gilberto Filaci
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

7.  A peptide antagonist disrupts NK cell inhibitory synapse formation.

Authors:  Gwenoline Borhis; Parvin S Ahmed; Bérénice Mbiribindi; Mohammed M Naiyer; Daniel M Davis; Marco A Purbhoo; Salim I Khakoo
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

8.  Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.

Authors:  Akash M Mehta; Ekaterina S Jordanova; Gemma G Kenter; Soldano Ferrone; Gert-Jan Fleuren
Journal:  Cancer Immunol Immunother       Date:  2007-07-12       Impact factor: 6.968

Review 9.  Effects of Peptide on NK cell-mediated MHC I recognition.

Authors:  Sorcha A Cassidy; Kuldeep S Cheent; Salim I Khakoo
Journal:  Front Immunol       Date:  2014-03-31       Impact factor: 7.561

10.  Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens.

Authors:  Shelly Kalaora; Eilon Barnea; Efrat Merhavi-Shoham; Nouar Qutob; Jamie K Teer; Nilly Shimony; Jacob Schachter; Steven A Rosenberg; Michal J Besser; Arie Admon; Yardena Samuels
Journal:  Oncotarget       Date:  2016-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.